Miles Prince is the Director of the Centre for Blood Cell Therapy at the Peter MacCallum Cancer Centre in Melbourne, Director of Molecular Oncology and Cancer Immunology at the Epworth Hospital, as well as holding full Professorships at both The University of Melbourne and Monash University.
Professor Prince treats all types of blood disorders, including anemia, blood clotting, and all blood-related cancers. He runs an active research group working towards the development of stem cell research and a better understanding of the role of the immune system in blood cancer development. In 1995 he set up the Centre for Blood Cell Therapies at Peter MacCallum Cancer Centre, which includes GMP laboratories for cell-based therapies including CAR-T cell protocols. His clinical research focuses on myeloma, T cell lymphoma, and immune-based therapies.
Professor Prince obtained a Bachelor of Medicine (Hons), a Bachelor of Surgery (Hons) and a Doctor of Medicine (Thesis) from Monash University. He trained in Melbourne, Sydney, and Toronto.
He has published more than 400 articles in peer-reviewed journals, and is a member of several international hematology societies, including the Australian, American and European Societies of Haematology and Oncology. He serves on the board of the International Society of Cutaneous Lymphoma, the International Waldenstrom's Macroglobulinemia Foundation and is Chairman of the Medical Scientific Advisory Group of Myeloma Australia. In 2014 his work was given wider recognition when he was awarded Member of the Order of Australia (general division) for significant services to blood cancer research, patient care and philanthropic leadership. He is a member of the scientific advisory board for the Lymphoma Hub and more recently he joined the steering committee of the Multiple Myeloma Hub.